Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

By MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

PSX Closing Bell: Holding Ground

BML Board authorizes CEO to execute deposit deal

Ghani Global secures SECP approval for share issuance

Name	Price/Vol	%Chg/NChg
KSE100	130,686.66 280.01M	0.26% 342.63
ALLSHR	81,305.25 897.01M	0.35% 281.26
KSE30	39,945.45 114.02M	0.09% 37.19
KMI30	190,698.05 148.61M	0.61% 1163.05
KMIALLSHR	55,074.15 495.43M	0.53% 290.50
BKTi	34,568.40 28.73M	-1.07% -372.33
OGTi	28,739.35 22.59M	1.57% 443.29

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	110,300.00	110,525.00 110,105.00	-115.00 -0.10%
BRENT CRUDE	68.76	68.89 68.73	-0.04 -0.06%
RICHARDS BAY COAL MONTHLY	97.50	0.00 0.00	-0.75 -0.76%
ROTTERDAM COAL MONTHLY	108.45	109.80 108.45	-0.55 -0.50%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	67.03	67.18 66.99	0.03 0.04%
SUGAR #11 WORLD	16.37	16.40 15.44	0.79 5.07%